Skip to main content
. 2020 Jan 14;21(2):515. doi: 10.3390/ijms21020515
CAR Chimeric antigen receptor
BiTE Bispecific T cell engager
scFv Single chain variable fragment
HER2 Human epidermal growth factor receptor 2
EGFRvIII Human epidermal growth factor receptor variant III
MHC Major Histocompatibility Complex
MS Mass spectrometry
CDR Complementarity determining region
CGA Cancer germline antigen
TAA Tumour associated antigen
TCR T cell receptor
TSA Tumour specific antigen